FormWeb • emtricitabine-tenofovir

Legacy Health

Approved Hospital Formulary

Pharmacy - Home (sharepoint.com) Contact Pharmacy

Search by class Show Therapeutic Classes

Legacy Hazardous Drugs Do Not Tube List

Add Formweb to your mobile device

Android iOS

Report an iCare

Legacy Health

Approved Hospital Formulary

Pharmacy - Home (sharepoint.com) Contact Pharmacy

Search results for:

emtricitabine-tenofovir

emtricitabine-tenofovir

Drug Name	Form	Strength	Notes
Truvada (emtricitabine-tenofovir disoproxil fumarate)	TABLET, ORAL	100 mg-150 mg; 133 mg-200 mg; 167 mg-250 mg; 200 mg-300 mg
Descovy (emtricitabine-tenofovir alafenamide fumarate)	TABLET, ORAL	120 mg-15 mg; 200 mg-25 mg

VIEW MORE HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors

Last updated: Feb. 22, 2023

Black Box Warning: Emtricitabine: Lactic acidosis, severe hepatomegaly; hepB co-infection
Black Box Warning: Tenofovir: lactic acidosis, severe hepatomegaly; hepB co-infection

This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.